Free Trial

Rocket Lab (NASDAQ:RKLB) Posts Quarterly Earnings Results, Misses Expectations By $0.05 EPS

Rocket Lab logo with Industrials background
Image from MarketBeat Media, LLC.

Key Points

  • Rocket Lab posted record third-quarter revenue of $267.8 million, up 73% year over year and above the $257.2 million consensus estimate, but its $0.12-per-share loss was $0.05 worse than expected.
  • Demand strengthened, with backlog reaching a record $3.57 billion and Neutron booking its first 16 launches. The company forecast fourth-quarter revenue of $270 million–$290 million.
  • Neutron’s first launch has been pushed to 2027 after a defect was found in a propellant-tank dome; elevated development costs are expected to contribute to negative free cash flow in Q4.
  • Five stocks we like better than Rocket Lab.

Rocket Lab (NASDAQ:RKLB - Get Free Report) issued its earnings results on Monday. The rocket manufacturer reported ($0.12) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.07) by ($0.05), FiscalAI reports. Rocket Lab had a negative net margin of 21.51% and a negative return on equity of 6.48%. The business had revenue of $267.83 million for the quarter, compared to the consensus estimate of $257.21 million.

Here are the key takeaways from Rocket Lab's conference call:

  • Rocket Lab reported record Q3 revenue of $267.8 million, up 73% year over year, and GAAP and non-GAAP gross margins exceeded guidance. Q4 revenue is forecast at $270 million–$290 million.
  • Backlog reached a record $3.57 billion, up 52% sequentially, following 54 launch bookings and substantial Space Systems awards. Neutron’s first 16 launches are booked, with multiple contracts priced at a $70 million base rate.
  • Space Systems delivered $214.8 million in quarterly revenue and had $1.7 billion in backlog; 55-plus spacecraft are in development or production. Management cited strong demand across government, commercial and component businesses.
  • Neutron’s first launch has shifted to 2027 after defects were found in a propellant-tank dome; the replacement is being built and tested. Development spending and investment in production remain elevated, and management expects negative free cash flow in Q4.
  • The Iridium acquisition is fully financed and received overwhelming shareholder approval, but regulatory approvals remain outstanding. Rocket Lab ended Q3 with about $4.7 billion in liquidity, aided by $2.4 billion in gross proceeds from its completed at-the-market share offering.

Rocket Lab Price Performance

RKLB traded up $5.79 during trading hours on Monday, hitting $58.86. The company's stock had a trading volume of 31,229,231 shares, compared to its average volume of 22,768,348. The business's 50-day moving average price is $62.45 and its 200-day moving average price is $78.80. Rocket Lab has a 12 month low of $37.57 and a 12 month high of $151.00. The stock has a market cap of $35.22 billion, a price-to-earnings ratio of -217.99 and a beta of 3.15. The company has a current ratio of 5.48, a quick ratio of 4.98 and a debt-to-equity ratio of 0.01.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on the stock. Cantor Fitzgerald restated a "mixed" rating and set a $122.00 target price on shares of Rocket Lab in a research report on Thursday, October 15th. TD Cowen reiterated a "buy" rating and issued a $90.00 price target on shares of Rocket Lab in a report on Thursday, October 15th. Raymond James Financial began coverage on shares of Rocket Lab in a research note on Friday, September 11th. They issued an "outperform" rating and a $80.00 price target on the stock. Citizens Jmp dropped their price objective on shares of Rocket Lab from $130.00 to $90.00 and set a "market outperform" rating for the company in a report on Friday, October 16th. Finally, Needham & Company LLC reissued a "buy" rating and set a $120.00 price objective on shares of Rocket Lab in a report on Friday, October 16th. Three analysts have rated the stock with a Strong Buy rating, fourteen have given a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $102.05.

Get Our Latest Report on RKLB

Insider Buying and Selling

In related news, CFO Adam Spice sold 140,157 shares of Rocket Lab stock in a transaction dated Thursday, October 1st. The stock was sold at an average price of $70.82, for a total value of $9,925,918.74. Following the completion of the transaction, the chief financial officer owned 1,155,967 shares in the company, valued at approximately $81,865,582.94. This trade represents a 10.81% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Nina Armagno sold 10,926 shares of the firm's stock in a transaction that occurred on Monday, November 2nd. The shares were sold at an average price of $52.78, for a total value of $576,674.28. Following the completion of the sale, the director directly owned 100,496 shares of the company's stock, valued at $5,304,178.88. The trade was a 9.81% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 551,832 shares of company stock valued at $34,940,037 in the last quarter. 8.40% of the stock is currently owned by insiders.

Key Stories Impacting Rocket Lab

Here are the key news stories impacting Rocket Lab this week:

  • Positive Sentiment: Revenue reached a record $267.8 million, topping analyst expectations of about $257.2 million. The company also reported positive GAAP operating cash flow and forecast record fourth-quarter revenue with gross-margin expansion. Rocket Lab third-quarter results and outlook
  • Positive Sentiment: Commercial momentum was a standout: quarterly backlog grew 52% sequentially to $1.2 billion, while Rocket Lab secured more than $515 million in Neutron launch deals. Neutron’s backlog reached 16 missions, and its base launch price increased to $70 million—evidence of customer demand ahead of the rocket’s debut. Neutron launch deals
  • Neutral Sentiment: Investors had bid RKLB higher ahead of earnings, with attention on Neutron’s timeline, margins, and cash needs. That elevated setup may have made the stock particularly sensitive to the results. Rocket Lab rebounds into earnings
  • Negative Sentiment: Despite the revenue beat, Rocket Lab’s loss of $0.12 per share was wider than the $0.07 loss analysts expected. Reports of after-hours weakness suggest investors may have focused on the miss and remaining execution risks, including Neutron’s delayed timeline. Rocket Lab backlog and earnings After-hours trading report

Rocket Lab Company Profile

(Get Free Report)

Rocket Lab is a space company that provides launch services and spacecraft and satellite systems for commercial, civil, and national security customers. Founded in 2006 by Peter Beck, the company operates internationally, with headquarters in Long Beach, California, and launch operations in New Zealand and the United States.

Its launch business centers on Electron, a small orbital rocket designed to carry satellites to space, and HASTE, a suborbital vehicle used for hypersonic test missions.

See Also

Earnings History for Rocket Lab (NASDAQ:RKLB)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Rocket Lab Right Now?

Before you consider Rocket Lab, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rocket Lab wasn't on the list.

While Rocket Lab currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines